{
"id":"mk19_a_id_t70",
"number":70,
"bookId":"id",
"title":{
"__html":"Postexposure Management of Health Care Personnel following Percutaneous or Mucosal Exposure to Hepatitis B"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"b322ec",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 70. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t70"
}
]
},
"Postexposure Management of Health Care Personnel following Percutaneous or Mucosal Exposure to Hepatitis B"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"13d75a",
"class":"col hd l",
"children":[
"HCP Status",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"41e78b",
"class":"col hd l",
"children":[
"Source Patient HBsAg + or Status Unknown"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"778449",
"class":"col hd l",
"children":[
"Source Patient HBsAg −"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aa4281",
"class":"cell txt l",
"children":[
"Vaccine responder",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f51a49",
"class":"cell txt l",
"children":[
"No action needed"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f51a49",
"class":"cell txt l",
"children":[
"No action needed"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0e20b3",
"class":"cell txt l",
"children":[
"Vaccine nonresponder",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
" after 6 doses"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"313d5c",
"class":"cell txt l",
"children":[
"HBIG",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
" × 2 separated by 1 month"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f51a49",
"class":"cell txt l",
"children":[
"No action needed"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ac0fdf",
"class":"cell txt l",
"children":[
"If vaccine response unknown, test HCP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"186cd1",
"class":"cell txt li",
"children":[
"Anti-HBs <10 mU/mL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c404a2",
"class":"cell txt l",
"children":[
"HBIG",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
" × 1"
]
},
" ",
{
"type":"p",
"hlId":"df5e18",
"class":"cell txt l",
"children":[
"Initiate revaccination"
]
},
" ",
{
"type":"p",
"hlId":"01d5cc",
"class":"cell txt l",
"children":[
"Postvaccination serologic testing",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"df5e18",
"class":"cell txt l",
"children":[
"Initiate revaccination"
]
},
" ",
{
"type":"p",
"hlId":"01d5cc",
"class":"cell txt l",
"children":[
"Postvaccination serologic testing",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ece4a6",
"class":"cell txt li",
"children":[
"Anti-HBs ≥10 mU/mL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f51a49",
"class":"cell txt l",
"children":[
"No action needed"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f51a49",
"class":"cell txt l",
"children":[
"No action needed"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"97cfbb",
"class":"cell txt l",
"children":[
"Unvaccinated or incompletely vaccinated"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c404a2",
"class":"cell txt l",
"children":[
"HBIG",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
" × 1"
]
},
" ",
{
"type":"p",
"hlId":"376c24",
"class":"cell txt l",
"children":[
"Complete vaccination"
]
},
" ",
{
"type":"p",
"hlId":"01d5cc",
"class":"cell txt l",
"children":[
"Postvaccination serologic testing",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"376c24",
"class":"cell txt l",
"children":[
"Complete vaccination"
]
},
" ",
{
"type":"p",
"hlId":"01d5cc",
"class":"cell txt l",
"children":[
"Postvaccination serologic testing",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
}
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"anti-HBs = antibody to hepatitis B surface antigen; HBIG = hepatitis B immune globulin; HBsAg = hepatitis B surface antigen; HCP = health care personnel."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"HCP who have anti-HBs <10 mU/mL, or who are unvaccinated or incompletely vaccinated, and sustain an exposure to a source patient who is HBsAg-positive or has unknown HBsAg status, should undergo baseline testing for HBV infection as soon as possible after exposure, and follow-up testing approximately 6 months later. Initial baseline tests consist of total anti–hepatitis B core antigen (anti-HBc); testing at approximately 6 months consists of HBsAg and total anti-HBc."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Documented response after complete vaccination series and/or anti-HBs ≥10 mU/mL."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"A nonresponder is defined as a person with anti-HBs <10 mU/mL after ≥6 doses of hepatitis B vaccine."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"HBIG should be administered intramuscularly as soon as possible after exposure when indicated. The effectiveness of HBIG when administered >7 days after percutaneous, mucosal, or nonintact skin exposures is unknown."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
},
"Should be performed 1 to 2 months after the last dose of the HepB vaccine series (and 4-6 months after administration of HBIG to avoid detection of passively administered anti-HBs) using a quantitative method that allows detection of the protective concentration of anti-HBs (≥10 mU/mL)."
],
[
"Adapted from Schillie S, Murphy TV, Sawyer M, et al; Centers for Disease Control and Prevention (CDC). CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013;62:1-19. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/24352112",
"target":"_blank"
},
"children":[
"PMID: 24352112"
]
}
]
]
}